Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data.
Maxime BoussageonAurélie SwalduzChristos ChouaidOlivier BylickiPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)